The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

[1]  Jian-Min Yuan,et al.  Environmental factors and risk for hepatocellular carcinoma. , 2004, Gastroenterology.

[2]  F. Carvalho,et al.  Nonalcoholic fatty liver and insulin resistance among petrochemical workers. , 2005, JAMA.

[3]  J. Pekow,et al.  Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis , 2007, Cancer.

[4]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[5]  Joong-Won Park.  [Hepatocellular carcinoma in Korea: introduction and overview]. , 2005, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[6]  J. Olsen,et al.  Obesity and cancer risk: a Danish record-linkage study. , 1994, European journal of cancer.

[7]  H. Ishii.  Hepatocellular carcinoma and non‐alcoholic fatty liver disease: Major liver diseases emerging from the Asia‐Pacific Region , 2006, Journal of gastroenterology and hepatology.

[8]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[9]  Neil D Theise,et al.  Hepatic precancerous lesions and small hepatocellular carcinoma. , 2007, Gastroenterology clinics of North America.

[10]  F. Carvalho,et al.  Nonalcoholic Fatty Liver and Insulin Resistance Among PetrochemicalWorkers , 2005 .

[11]  Jong Hyeok Kim,et al.  [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?]. , 2005, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[12]  Y. Nakanuma,et al.  Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. , 1998, Gastroenterology.

[13]  L. Garfinkel,et al.  Variations in mortality by weight among 750,000 men and women. , 1979, Journal of chronic diseases.

[14]  A. Clouston,et al.  Steatosis: Co‐factor in other liver diseases , 2005, Hepatology.

[15]  T. Roskams.  Liver stem cells and their implication in hepatocellular and cholangiocarcinoma , 2006, Oncogene.

[16]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[17]  Derek Y. Chiang,et al.  24 A NOVEL MOLECULAR CLASSIFICATION OF HCV-RELATED HEPATOCELLULAR CARCINOMA (HCC) BASED ON INTEGRATIVE GENOMIC ANALYSIS , 2008 .

[18]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[19]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[20]  S. Caldwell,et al.  Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.

[21]  J. Bruix,et al.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action , 1998 .

[22]  Chien-Jen Chen,et al.  Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B– and C–related risk , 2003, Hepatology.

[23]  Paola Pisani,et al.  Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.

[24]  M. Greenblatt,et al.  Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States? , 1999, Nutrition and cancer.

[25]  T. Roskams,et al.  Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. , 2003, The American journal of pathology.

[26]  M. Kumar,et al.  Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case–control study of 213 hepatocellular carcinoma patients from India , 2007, Journal of gastroenterology and hepatology.

[27]  N. Kato,et al.  Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  J. -. Kim,et al.  596 Is the incidence of cryptogenic hepatocellular carcinoma increasing in Korea , 2004 .

[29]  S. Thorgeirsson,et al.  Activation of NF‐κB and STAT3 in rat oval cells during 2‐acetylaminofluorene/partial hepatectomy‐induced liver regeneration , 2004, Hepatology.

[30]  H. Sørensen,et al.  Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends , 2007, International journal of cancer.

[31]  R. Fry,et al.  Hepatocellular carcinoma associated with liver-gender disruption in male mice. , 2007, Cancer research.

[32]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[33]  J. Bruix,et al.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. , 1998, Journal of hepatology.

[34]  L. Seeff.  Introduction: The burden of hepatocellular carcinoma. , 2004, Gastroenterology.

[35]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[36]  C. Vecchia.  Alcohol and liver cancer. , 2007 .

[37]  A. Suzuki,et al.  Non‐alcoholic steatohepatitis and hepatocellular carcinoma: Lessons from hepatocyte‐specific phosphatase and tensin homolog (PTEN)‐deficient mice , 2007, Journal of Gastroenterology and Hepatology.

[38]  Y. Sasaki.  Does oxidative stress participate in the development of hepatocellular carcinoma? , 2007, Journal of Gastroenterology.

[39]  F. Miglio,et al.  [Epidemiology of hepatocellular carcinoma]. , 1991, Minerva gastroenterologica e dietologica.

[40]  M. Richardson,et al.  Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis , 2005, Hepatology.

[41]  T. Therneau,et al.  Mortality and hospital utilization for hepatocellular carcinoma in the United States. , 2005, Gastroenterology.

[42]  S. Kubo,et al.  Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence , 2003, Cancer science.

[43]  E. Lesaffre,et al.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.

[44]  S. Park.  [Nonalcoholic steatohepatitis: pathogenesis and treatment]. , 2008, The Korean journal of hepatology.

[45]  H. El‐Serag,et al.  The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans , 2001, American Journal of Gastroenterology.

[46]  J. Marrero,et al.  NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.

[47]  M. Tang,et al.  The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. , 2002, Carcinogenesis.

[48]  S. Caldwell,et al.  The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. , 2004, Journal of hepatology.

[49]  G. Gores,et al.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. , 2003 .

[50]  H. Tilg,et al.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. , 2007, Gastroenterology.

[51]  C. Howell,et al.  Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[52]  H. Adami,et al.  Role of diabetes mellitus in the etiology of hepatocellular carcinoma. , 2000, Journal of the National Cancer Institute.

[53]  T. Fujii,et al.  Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. , 2008, JAMA.

[54]  K. Eguchi,et al.  Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection , 2003, Cancer.

[55]  E. Rourke,et al.  Fasting and medical issues during Ramadan. , 2005, JAMA.

[56]  K. Nouso,et al.  Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus‐associated hepatocellular carcinoma , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[57]  G. Gores,et al.  Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status , 2003, American Journal of Gastroenterology.

[58]  N. Maria,et al.  Sex hormones and liver cancer , 2002, Molecular and Cellular Endocrinology.

[59]  H. Adami,et al.  A prospective study of obesity and cancer risk (Sweden) , 2004, Cancer Causes & Control.

[60]  Y. Higaki,et al.  Case–control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese , 2007, Cancer science.

[61]  J. Goodwin,et al.  Epidemiology of hepatocellular carcinoma in Hispanics in the United States. , 2007, Archives of internal medicine.

[62]  M. Greenblatt,et al.  Does aflatoxin B 1 play a role in the etiology of hepatocellular carcinoma in the United States , 1999 .

[63]  R. Eils,et al.  Etiology‐dependent molecular mechanisms in human hepatocarcinogenesis , 2007, Hepatology.

[64]  H. Tilg,et al.  [113] PROGRESSIVE FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS - ASSOCIATION WITH ALTERED REGENERATION AND A DUCTULAR REACTION , 2007 .

[65]  Chun-Yuh Yang,et al.  DOES ARSENIC EXPOSURE INCREASE THE RISK FOR LIVER CANCER? 1 , 2004, Journal of toxicology and environmental health. Part A.

[66]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[67]  H. Pitot.  Pathways of progression in hepatocarcinogenesis , 2001, The Lancet.

[68]  M. Yu,et al.  Epidemiology of hepatocellular carcinoma. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[69]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[70]  Chien-Jen Chen,et al.  Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. , 2005, Journal of the National Cancer Institute.

[71]  Sheng-Nan Lu,et al.  Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival , 2008, Journal of Gastroenterology.

[72]  R. Schulte‐Hermann,et al.  Biology of transforming growth factor β in hepatocarcinogenesis , 2001, Microscopy research and technique.

[73]  Akihiro Matsumoto,et al.  Hepatocellular carcinoma: recent trends in Japan. , 2004, Gastroenterology.

[74]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[75]  E. Bugianesi,et al.  Non-alcoholic steatohepatitis and cancer. , 2007, Clinics in liver disease.

[76]  Chien-Jen Chen,et al.  Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. , 2005, Cancer letters.